Octant
Octant is a precision medicine company developing next-generation small molecule therapeutics by merging biology, chemistry, and computation to engineer drugs that target complex cellular mechanisms. Its programs span protein misfolding and mistrafficking diseases, oncology, metabolism, and immunology, with lead candidate OCT-980 — a first-in-disease oral small molecule designed to correct protein misfolding for rhodopsin gene mutations in autosomal dominant retinitis pigmentosa. Octant is a portfolio company of 8vc. It publishes no public developer API, developer portal, or technical documentation; this profile is maintained in the API Evangelist network as a company record.
Octant is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Precision Medicine, Drug Discovery, and Therapeutics.
Octant’s developer surface includes engineering blog and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API